Execution...PressRelease April 3, 2018....Genenews said (QUOTE) After nearly two years of very careful (I like very careful) preparation, the pieces are in place, and it is now a matter of execution (END of QUOTE).
After that PressRelease, all of a sudden, things started to happen very fast, like never before in the history of Genenews.
-Genenews switched Billing Company...
-Genenews restarted its Billing Process...
-Genenews entered into a partnership with AIM Laboratories...
-Genenews named David Byram Chief Commercial Officer...
-Genenews formed a partnership with LifeX...
-Genenews expanded coverage by Health Insurance network...
-Genenews declared steady revenue increase 3 quarters in a row(small but nevertheless a big step forward)...
PressRelease Dec 28, 2018...genenews said (QUOTE) Genenews is preparing for a very active first quarter in 2019, with plans already in place for screening of high-risk employe groups, implementation of screening within large HealthCare, and collaborating with one or more large Physician Network. (END of QUOTE).
Already in place , I like that.
There seem to be a lots of similirarity between this PressRelease and the April 3, 2018 PressRelease (execution).
Will be very interesting to see execution in 2019.